Roche

The US Food and Drug Administration (FDA) has granted premarket approval to Roche’s new fully automated COBAS AmpliPrep / COBAS TaqMan CMV test to quantify cytomegalovirus (CMV) DNA in human plasma specimens.

The real-time polymerase chain reaction (PCR)-based CMV test, which is designed for use with the company’s COBAS AmpliPrep / COBAS TaqMan system, is used as an aid in the management of solid organ transplant patients who are undergoing anti-CMV therapy.

Go deeper with GlobalData

Premium Insights

The gold standard of business intelligence.

Find out more

The CMV DNA viral load information from the test can be used by physicians to manage CMV in patients whose immune system has been suppressed for solid organ transplantation.

The COBAS AmpliPrep / COBAS TaqMan system, which combines the COBAS AmpliPrep instrument for automated sample preparation and the COBAS TaqMan analyser real-time PCR for amplification and detection, can be used with the cobas p 630 instrument, which provides an integrated pre-analytical primary tube handling solution.

The AmpliPrep / COBAS TaqMan system also has parallel processing with other molecular diagnostics assays targeting hepatitis B virus, hepatitis C virus and human immunodeficiency virus diseases, according to the company.

Head of Roche Molecular Diagnostics, Paul Brown, said that with the test, laboratories have an FDA-approved option for standardised and automated CMV viral load testing that improves the laboratory’s workflow.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

“It provides physicians with clinically useful information to aid in the management of solid organ transplant patients with CMV disease,” Brown added.

Image: Roche headquarters in Basel, Switzerland. Photo courtesy of: F. Hoffmann-La Roche Ltd.